Common Stocks and Uncommon Profits and Other Writings

 Index 
2 8 9 
Monopolies, 200 
Montgomery Ward, 201 
Motorola, 51, 52, 189–190, 195, 220–222, 245–247 
N 
National Association of Securities Dealers,
126–127 
Needs, of investor, 79–88 
New-issue supply, 224 
New products, 92 
New York Stock Exchange, 128, 129, 171 
Nielsen, A. C., Co., 216–217 
Noble, Daniel, 246 
O 
Opportunity 
history vs., 255–257 
price vs., 249–251 
Overpriced stocks, 110–111, 131, 211 
Over-the-counter stocks, 124–129 
P 
Panic of 1873, 223, 256 
Past, clues from, 34–43 
Patents, 72–73 
Patience, 244–247 
People-effectiveness program, 193–195 
People factors, 187–197, 241–242, 254, 281–282 
Performance, 244–247 
Per-share earnings, past, 149–153 
Personnel relations, 66–67. See also Employees 
Pharmaceutical stocks 
appraisals of, 158–159, 257–258 
trade names and, 202 
Philco, 232 
Philosophy (of Philip A. Fisher) 
investment, summary, 275–277
maturing of, 252–265
origins of, 227–237
Pilot-plant operation, 92, 93 
Plants, first, 92–94 
Pools, stock, 238–239 

---

2 9 0
 
Price 
in buying true growth stock, 153–155 
of conservative investment. See Price-earnings ratio 
vs. opportunity, 249–251 
significant changes in, 212 
Price-earnings ratio 
definition, 207 
and growth, 130–132, 151–152, 153, 207–212, 213–217, 218–224,
234–235 
Price ranges, past, 147–149, 152–153 
Printed material, leads from, 165 
Processes, 53–54. See also Products 
Production, low-cost, 180–182 
Products, 47–53, 53–54, 254, 270, 271, 279–280, 282 
Professional advisor. See Financial advisors 
Profitability, 198–200, 205–206 
Profit margins, 62–63, 63–65, 184, 199–200, 205–206, 280, 282 
Profits, 62, 184 
short-range vs. long-range, 73–74 
Promotional companies, 123–124. See also Young companies 
Promotion from within, 188–189, 281